Isaac Sipo

627 total citations
12 papers, 338 citations indexed

About

Isaac Sipo is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Isaac Sipo has authored 12 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Isaac Sipo's work include Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (7 papers) and Viral Infections and Immunology Research (5 papers). Isaac Sipo is often cited by papers focused on Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (7 papers) and Viral Infections and Immunology Research (5 papers). Isaac Sipo collaborates with scholars based in Germany, Netherlands and Sweden. Isaac Sipo's co-authors include Wolfgang Poller, Henry Fechner, Lennart Suckau, Sandra Pinkert, Stefan Weger, Roland Vetter, Jens Kurreck, Carsten Tschöpe, Xiaomin Wang and Heinz Zeichhardt and has published in prestigious journals such as Circulation, Vaccine and Molecular Therapy.

In The Last Decade

Isaac Sipo

12 papers receiving 334 citations

Peers

Isaac Sipo
Jae-Hwan Nam South Korea
Lauren M. Drouin United States
Hadi M. Alzuherri United Kingdom
Anke Muth Germany
Cory Smith United Kingdom
Isaac Sipo
Citations per year, relative to Isaac Sipo Isaac Sipo (= 1×) peers Lennart Suckau

Countries citing papers authored by Isaac Sipo

Since Specialization
Citations

This map shows the geographic impact of Isaac Sipo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isaac Sipo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isaac Sipo more than expected).

Fields of papers citing papers by Isaac Sipo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isaac Sipo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isaac Sipo. The network helps show where Isaac Sipo may publish in the future.

Co-authorship network of co-authors of Isaac Sipo

This figure shows the co-authorship network connecting the top 25 collaborators of Isaac Sipo. A scholar is included among the top collaborators of Isaac Sipo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isaac Sipo. Isaac Sipo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Poller, Wolfgang, Lennart Suckau, Henry Fechner, et al.. (2008). Abstract 3807: Chronic Cardiac-Targeted RNA Interference for the Treatment of Severe Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy. Circulation. 118. 1 indexed citations
3.
Fechner, Henry, Isaac Sipo, Dirk Westermann, et al.. (2008). Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy. Journal of Molecular Medicine. 86(9). 987–997. 65 indexed citations
4.
Sipo, Isaac, Henry Fechner, Sandra Pinkert, et al.. (2007). Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction. Gene Therapy. 14(18). 1319–1329. 35 indexed citations
5.
Fechner, Henry, Sandra Pinkert, Isaac Sipo, et al.. (2007). Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Therapy. 14(12). 960–971. 37 indexed citations
6.
Fechner, Henry, Lennart Suckau, Jens Kurreck, et al.. (2006). Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban. Gene Therapy. 14(3). 211–218. 31 indexed citations
7.
Suckau, Lennart, Henning Witt, Carsten Skurk, et al.. (2006). Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. Journal of Molecular Medicine. 85(3). 257–271. 67 indexed citations
8.
Fechner, Henry, Xiaomin Wang, Lennart Suckau, et al.. (2006). A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication. Journal of Biotechnology. 127(4). 560–574. 11 indexed citations
9.
Sipo, Isaac, Lennart Suckau, Sandra Pinkert, et al.. (2006). 844. A Single Vector-Dependent, Doxycycline- Regulatable, Lung Cancer Specific Oncolytic Adenovirus. Molecular Therapy. 13. S326–S326. 1 indexed citations
10.
11.
Sipo, Isaac, Xiaomin Wang, Jürgen Eberle, et al.. (2005). An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy. Journal of Molecular Medicine. 84(3). 215–225. 31 indexed citations
12.
Wang, Xiaomin, et al.. (2004). Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses. Molecular Therapy. 11(4). 563–577. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026